Literature DB >> 10590504

New devices and hybrid therapies and new devices for treatment of atrial fibrillation.

R B Krol1, S Saksena, A Prakash.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10590504     DOI: 10.1023/a:1009875832060

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


× No keyword cloud information.
  39 in total

1.  Initial experience with intracardiac atrial defibrillation in patients with chronic atrial fibrillation.

Authors:  E Alt; C Schmitt; R Ammer; M Coenen; P Fotuhi; M Karch; R Blasini
Journal:  Pacing Clin Electrophysiol       Date:  1994-05       Impact factor: 1.976

2.  Electrophysiological effects of long, linear atrial lesions placed under intracardiac ultrasound guidance.

Authors:  J E Olgin; J M Kalman; M Chin; C Stillson; M Maguire; P Ursel; M D Lesh
Journal:  Circulation       Date:  1997-10-21       Impact factor: 29.690

3.  Testing different biphasic waveforms and capacitances: effect on atrial defibrillation threshold and pain perception.

Authors:  G Tomassoni; K H Newby; M M Kearney; M J Brandon; H Barold; A Natale
Journal:  J Am Coll Cardiol       Date:  1996-09       Impact factor: 24.094

4.  Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study.

Authors:  L Bianconi; M Mennuni; V Lukic; A Castro; M Chieffi; M Santini
Journal:  J Am Coll Cardiol       Date:  1996-09       Impact factor: 24.094

5.  Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias. A randomized, placebo-controlled, crossover trial in patients tolerating oral therapy.

Authors:  E L Pritchett; E A McCarthy; W E Wilkinson
Journal:  Ann Intern Med       Date:  1991-04-01       Impact factor: 25.391

6.  Clinical shock tolerability and effect of different right atrial electrode locations on efficacy of low energy human transvenous atrial defibrillation using an implantable lead system.

Authors:  N S Lok; C P Lau; H F Tse; G M Ayers
Journal:  J Am Coll Cardiol       Date:  1997-11-01       Impact factor: 24.094

7.  A focal source of atrial fibrillation treated by discrete radiofrequency ablation.

Authors:  P Jaïs; M Haïssaguerre; D C Shah; S Chouairi; L Gencel; M Hocini; J Clémenty
Journal:  Circulation       Date:  1997-02-04       Impact factor: 29.690

8.  Radiofrequency catheter ablation of the atria reduces inducibility and duration of atrial fibrillation in dogs.

Authors:  A Elvan; H P Pride; J N Eble; D P Zipes
Journal:  Circulation       Date:  1995-04-15       Impact factor: 29.690

9.  Late occurrence of incessant atrial tachycardia following the maze procedure.

Authors:  K A Ellenbogen; H R Hawthorne; M K Belz; B S Stambler; M L Cherwek; M A Wood
Journal:  Pacing Clin Electrophysiol       Date:  1995-02       Impact factor: 1.976

10.  Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats.

Authors:  M C Wijffels; C J Kirchhof; R Dorland; M A Allessie
Journal:  Circulation       Date:  1995-10-01       Impact factor: 29.690

View more
  3 in total

1.  Atrial fibrillation recurrence after internal cardioversion: prognostic importance of electrophysiological parameters.

Authors:  M Biffi; G Boriani; M Bartolotti; L Bacchi Reggiani; R Zannoli; A Branzi
Journal:  Heart       Date:  2002-05       Impact factor: 5.994

Review 2.  Hybrid therapy of atrial fibrillation: algorithms and outcome.

Authors:  Sanjeev Saksena; Nandini Madan
Journal:  J Interv Card Electrophysiol       Date:  2003-10       Impact factor: 1.900

Review 3.  Rationale and patient selection for "hybrid" drug and device therapy in atrial and ventricular arrhythmias.

Authors:  A John Camm; Irina Savelieva
Journal:  J Interv Card Electrophysiol       Date:  2003-10       Impact factor: 1.900

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.